Zydus Lifesciences Legal & Regulatory
Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.
- Value
- ₹55.46 Cr
ALFA Filings
Every announcement, straight from the exchange
Every Zydus Lifesciences legal & regulatory announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.
Zydus Lifesciences received a demand for ₹108.54 Crore in deficient stamp duty and penalties. The company is evaluating legal remedies regarding the order.
Zydus Lifesciences' subsidiary ZHL secured favorable appellate orders dropping GST demands totaling ₹0.42 Crore. This significantly reduces the company's potential tax liability and penalty exposure.
Zydus Lifesciences received an appeal order upholding a ₹1.18 Crore GST demand and penalty. The company intends to file a second appeal before GSTAT.
Zydus Lifesciences' subsidiary, Zydus VTEC Limited, received a GST demand and penalty order totaling ₹1.80 Crore for the period September 2020 to March 2023. The issue pertains to alleged inadmissible Input Tax Credit. The company intends to appeal the order and states there is no material financial impact.